Targeted copy number variant identification across the neurodegenerative disease spectrum

Although genetic factors are known to contribute to neurodegenerative disease susceptibility, there remains a large amount of heritability unaccounted for across the diagnoses. Copy number variants (CNVs) contribute to these phenotypes, but their presence and influence on disease state remains relatively understudied.

[1]  Pradeep Reddy Raamana,et al.  Characteristics of the Ontario Neurodegenerative Disease Research Initiative cohort , 2022, Alzheimer's & dementia : the journal of the Alzheimer's Association.

[2]  N. Pedersen,et al.  Measuring heritable contributions to Alzheimer’s disease: polygenic risk score analysis with twins , 2022, Brain communications.

[3]  OUP accepted manuscript , 2022, Brain Communications.

[4]  Ryan L. Collins,et al.  The mutational constraint spectrum quantified from variation in 141,456 humans , 2020, Nature.

[5]  John F. Robinson,et al.  Use of next-generation sequencing to detect LDLR gene copy number variation in familial hypercholesterolemia , 2020 .

[6]  S. Wilton,et al.  ALS Genetics, Mechanisms, and Therapeutics: Where Are We Now? , 2019, Front. Neurosci..

[7]  J. Rohrer,et al.  An update on genetic frontotemporal dementia , 2019, Journal of Neurology.

[8]  Ming Zhang,et al.  Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease , 2018, Journal of visualized experiments : JoVE.

[9]  I. Deary,et al.  Genetic risk for neurodegenerative disorders, and its overlap with cognitive ability and physical function , 2017, bioRxiv.

[10]  J. Hendrikse,et al.  Cerebral disease in a nationwide Dutch pseudoxanthoma elasticum cohort with a systematic review of the literature , 2017, Journal of the Neurological Sciences.

[11]  S. Cavallaro,et al.  Copy Number Variations in Amyotrophic Lateral Sclerosis: Piecing the Mosaic Tiles Together through a Systems Biology Approach , 2017, Molecular Neurobiology.

[12]  S. Cavallaro,et al.  Copy Number Variants in Alzheimer’s Disease , 2016, Journal of Alzheimer's disease : JAD.

[13]  Lorne Zinman,et al.  The Ontario Neurodegenerative Disease Research Initiative (ONDRI) , 2016, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.

[14]  John F. Robinson,et al.  The ONDRISeq panel: custom-designed next-generation sequencing of genes related to neurodegeneration , 2016, npj Genomic Medicine.

[15]  P. Heutink,et al.  A novel homozygous DJ1 mutation causes parkinsonism and ALS in a Turkish family. , 2016, Parkinsonism & related disorders.

[16]  C. Broeckhoven,et al.  Molecular genetics of early-onset Alzheimer's disease revisited , 2016, Alzheimer's & Dementia.

[17]  E. Sorokina,et al.  Identification of an Alu‐repeat‐mediated deletion of OPTN upstream region in a patient with a complex ocular phenotype , 2015, Molecular genetics & genomic medicine.

[18]  S. Terry,et al.  Copy number variation in the ATP-binding cassette transporter ABCC6 gene and ABCC6 pseudogenes in patients with pseudoxanthoma elasticum , 2015, Molecular genetics & genomic medicine.

[19]  R. Tanzi,et al.  Rare autosomal copy number variations in early-onset familial Alzheimer’s disease , 2014, Molecular Psychiatry.

[20]  Mohamad Saad,et al.  Using genome-wide complex trait analysis to quantify 'missing heritability' in Parkinson's disease. , 2013, Human molecular genetics.

[21]  Yusuke Nakamura,et al.  Novel deletion mutations of OPTN in amyotrophic lateral sclerosis in Japanese , 2012, Neurobiology of Aging.

[22]  D. Pinto,et al.  Genome-Wide Survey of Large Rare Copy Number Variants in Alzheimer’s Disease Among Caribbean Hispanics , 2012, G3: Genes | Genomes | Genetics.

[23]  Tian Tian,et al.  Hypothesis of optineurin as a new common risk factor in normal-tension glaucoma and Alzheimer's disease. , 2011, Medical hypotheses.

[24]  Marc Cruts,et al.  Genetic Etiology of Parkinson Disease Associated with Mutations in the SNCA, PARK2, PINK1, PARK7, and LRRK2 Genes: A Mutation Update , 2010, Human mutation.

[25]  Takeo Kato,et al.  Mutations of optineurin in amyotrophic lateral sclerosis , 2010, Nature.

[26]  P. Shaw,et al.  Oxidative stress in ALS: key role in motor neuron injury and therapeutic target. , 2010, Free radical biology & medicine.

[27]  Manuel Corpas,et al.  DECIPHER: Database of Chromosomal Imbalance and Phenotype in Humans Using Ensembl Resources. , 2009, American journal of human genetics.

[28]  P. Heutink,et al.  Genotypic and phenotypic characteristics of Dutch patients with early onset Parkinson's disease , 2009, Movement disorders : official journal of the Movement Disorder Society.

[29]  A. J. Slater,et al.  Candidate single-nucleotide polymorphisms from a genomewide association study of Alzheimer disease. , 2008, Archives of neurology.

[30]  R. Redon,et al.  Relative Impact of Nucleotide and Copy Number Variation on Gene Expression Phenotypes , 2007, Science.

[31]  Daniel Offen,et al.  Role of DJ-1 in Parkinson's disease , 2007, Journal of Molecular Neuroscience.

[32]  D. Conrad,et al.  Global variation in copy number in the human genome , 2006, Nature.

[33]  L. Feuk,et al.  Structural variation in the human genome , 2006, Nature Reviews Genetics.

[34]  P. Ragonese,et al.  DJ‐1 mutations and parkinsonism‐dementia‐amyotrophic lateral sclerosis complex , 2005, Annals of neurology.

[35]  D. Pavlović,et al.  Cerebral Small Vessel Disease in Pseudoxanthoma Elasticum: Three Cases , 2005, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.

[36]  B. Oostra,et al.  DJ-1( PARK7), a novel gene for autosomal recessive, early onset parkinsonism , 2003, Neurological Sciences.

[37]  M. Kool,et al.  Mutations in ABCC6 cause pseudoxanthoma elasticum , 2000, Nature Genetics.

[38]  M. Lebwohl,et al.  Pseudoxanthoma elasticum: mutations in the MRP6 gene encoding a transmembrane ATP-binding cassette (ABC) transporter. , 2000, Proceedings of the National Academy of Sciences of the United States of America.